A RECENT large-scale study has examined the association between metformin use and the development of diabetic peripheral ...

Researchers have found in a new research that Metformin shows promise in promoting periodontal tissue repair following ...

There was no difference in the A1C threshold at which monotherapy was converted to dual therapy between the three metformin-treated groups. The beneficial effect of metformin on weight loss was ...

Metformin has long been the cornerstone of therapy for glycemic control in patients with Type 2 diabetes worldwide. It is recommended as first-line therapy by all major diabetes clinical practice ...

With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and day-long plasma insulin response may actually decrease.

Researchers found metformin, a common diabetes drug, may protect against blood cancer AML by targeting pre-cancerous cells.

Research from the University of Cambridge shows that metformin, a widely used and affordable diabetes drug, could prevent a ...

Researchers from the US have shown that combination therapy with sitagliptin and metformin results in a substantial and additive glycemic improvement in patients with type 2 diabetes. Sitagliptin ...

Glipizide/metformin HCl; 2.5mg/250mg, 2.5mg/500mg, 5mg/500mg; tabs. Adjunct to diet and exercise in type 2 diabetes, as initial therapy or as second-line therapy when response to a sulfonylurea or ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.